Language selection

Search


Top of page

Announcement of Opportunity (AO) for Health and Life Science (HLS) Research on International Space Station (ISS) (ISS AO 2026)

On this page

  1. INTRODUCTION
  2. AO OBJECTIVES
  3. ELIGIBILITY CRITERIA
  4. APPLICATIONS
  5. EVALUATION
  6. FUNDING
  7. FUNDING AGREEMENTS
  8. FREQUENTLY ASKED QUESTIONS (FAQ)
  9. APPENDIX 1: Examples of Companies Enabling Life Science Research in Microgravity Environments
  10. APPENDIX 2: Structure for the detailed project description
  11. APPENDIX 3: Description of Eligibility Assessment Criteria
  12. APPENDIX 4: Description of Programmatic Criteria
  13. APPENDIX 5: Description of Evaluation Criteria for Scientific Merit

Publication date

Applications due .

Summary of Key Information

  • Eligible recipients: Canadian post-secondary institutions and Not-for-profit organizations established and operating in Canada that have research included in their institutional mandate
  • Funding Type: Contribution
  • Maximum amount per project: $900,000
  • Estimated Number of projects under the AO: 4
  • Total Funding Under this AO: $3,600,000
  • Estimated Start Date of Resulting Projects:
  • Information regarding the webinar

 

1 INTRODUCTION

Future human exploration of space is expected to go beyond Low Earth Orbit (LEO) to targets such as the Moon and Mars. The resulting expeditions will lead to extended periods of exposure to different gravitational fields and space radiation in addition to confinement and isolation in the extreme environment of space, all of which are linked to substantial health and performance risks for astronauts.

The Canadian Space Agency (CSA) is interested in human spaceflight and maintaining a healthy and highly qualified astronaut corps capable of participating in space exploration missions. Also, the CSA aims to enable scientific opportunities and global partnerships, and to harness space to solve everyday challenges for Canadians.

To support this goal, the CSA's Health and Life Sciences (HLS) group supports activities generating knowledge in fields that sustain human space flights, mitigate health risks, and lead to countermeasures for those missions. Canadian utilization of the International Space Station (ISS) focuses on research that addresses health risks of spaceflight. Therefore, the proposed research should clearly address these health risks (Table 1). Eligible proposals must lead to a better understanding of these risks or generate information supporting the development of countermeasures.

The proposed research must be conducted using research models such as cells, organoids, cell-free systems, microorganisms and model organisms (except rodents) that will be handled in specialized research facilities on the ISS.

This AO is consistent with the terms and conditions of the CSA Class Grant and Contribution Program to Support Research, Awareness, and Learning in Space Science and Technology – Research Component (the G&C Program).

Applicants are asked to read the following AO thoroughly before submitting their applications. This AO was prepared to help applicants complete the application process, and outlines key elements, including mandatory criteria for eligibility, details on eligible projects and the selection process.

2 AO OBJECTIVES

Through this AO, the CSA is seeking to financially support Canadian researchers who will design and implement scientific protocols to investigate health risks associated with space travel. More specifically, submitted projects shall clearly demonstrate that they:

3 ELIGIBILITY CRITERIA

In this section

3.1 Eligible Recipients

To be eligible under this AO, recipients for contributions must meet one (1) of the eligibility criteria as follows:

  • Canadian post-secondary institutions, defined as a Canadian university or college (including CEGEPs in Quebec) that has provincial accreditation to grant degrees, diplomas, certificates, or other recognized qualifications.
  • Not-for-profit organizations established and operating in Canada that have research included in their institutional mandate, and that have a standing Research Ethics Board (REB)/ Animal Care Committee (when required), or that delegate this responsibility to another institution's recognized board/committee.

3.2 Eligible Projects

Projects eligible for funding under this AO are those wherein eligible recipients submit projects for which a Canadian researcher is the Principal Investigator (PI) in a new research project. There is no limit on the number of proposals presented per investigator.

Projects must be original initiatives presented to the CSA. Projects submitted for funding to other space agency-led selection processes are not eligible under this AO. The PI must hold a traditionally recognized academic position such as professor, associate professor, assistant professor, or professor emeritus (post-doctoral fellows cannot be considered as PI). Individuals who are paid salary through someone else's research grant are not eligible as a PI.

Eligible projects are innovative space life science studies to be conducted on the ISS using research models such as cells, organoids, cell-free systems, microorganisms and model organisms (except rodents) to investigate space-related health risks identified in Table 1 in Section 3.3 or new countermeasures to these risks. However, the core of the proposed studies must focus on living systems. The study will use model systems proposed by the PI and handled by equipment from a third-party provider. The list of potential third-party providers can be found in Appendix 1. It is expected that the PI will contact one of these providers to obtain a quote for their services and include this cost in the proposal budget. The availability of these facilities will need to be confirmed before the project can be funded as demonstrated with a letter of intent or launch service agreement from the third-party provider to the PI. The agreement should include the rough order of magnitude (ROM) costs and a list of milestones leading to launch. Any costs associated with the letter of intent or launch service agreement are not reimbursable, if incurred prior to signing a contribution agreement with the CSA.

All development phases necessary for a project are eligible for funding. Any logical breakdown or combination of these phases can constitute a funded project under this AO. However, breaking down a project into numerous phases submitted as distinct proposals to obtain more than the maximum contribution under this AO is not allowed. Furthermore, the completion of a funded phase does not automatically guarantee funding of the remaining phases. Details of eligible costs of the projects financed under this AO are listed in Section 6.2. Selected recipients will be required to sign a collaboration agreement with the CSA.

3.3 Links with CSA priorities

To be eligible, projects supported under this AO must contribute to at least one (1) of the following CSA priorities (as stated in the Space Strategy for Canada and the 2025- CSA Departmental Plan):

  • Space information and technologies improve the lives of Canadians.
  • Improving remote medicine and health care: keeping astronauts healthy in deep space has many direct applications in health care today.

In accordance to its mandate, the activities selected must generate new knowledge and insight into the risks of human space flight to keep astronauts healthy in space (Space Strategy for Canada, ). Health risks targeted by CSA and associated with human space flights (i.e., future long-duration human spaceflight missions) are listed in Table 1.

Table 1 – Eligible Human Space Flight Risks
Category Mission risk resulting from or associated with:
Musculoskeletal and Cardiorespiratory Reduced muscle strength and aerobic capacity, and increased bone fragility.
Sensorimotor Sensory changes/dysfunctions.
Metabolism Metabolism and the effects of nutrient composition of diet on health during space missions.
Behavioural Health and Performance Psychosocial adaptation, stress and fatigue, cognitive deterioration, or issues with team dynamics.
Radiation Health and performance impairment associated with radiation damage.
Hypogravity Physiological adaptation (including Spaceflight-Associated Neuro-Ocular Syndrome) during transit (i.e., long duration exposure to microgravity) and sojourn on planetary surfaces. Note that physiological adaptation includes adaptation of human-associated microbial communities.
Environmental Exposure Mission and long-term health effects associated with exposure to toxic substances or virulent microorganisms

In addition to fundamental research on health risks of spaceflight, the CSA encourages proposals aiming to develop and test countermeasures to mitigate these risks. Furthermore, the following specific needs for health and medical support of spaceflight crews are relevant to this AO:

  • Additional methods to monitor disorders related to sleep and fatigue.
  • Approaches to better predict physiological changes in space with an impact on health or performance.
  • Interaction of nutritional and energy status and physiological systems.
  • Non-pharmacological approaches to musculoskeletal pain and injury management.
  • Research into non-cancer and cancer health risks due to space radiation exposure.
  • Research on/development of individualized radiation protection measures based on individual radiation sensitivities.

In addition to the risks listed in Table 1, the CSA will also evaluate if the proposal would contribute to advancing the understanding of similar health issues on Earth, could contribute to improving health and health care for all Canadians, or translate to applications on Earth, with specific emphasis on scientific advances that directly impact the delivery of health care to remote and isolated communities in Canada.

3.4 Links to the Class Grants and Contributions Program Objectives

To be eligible, projects supported under this AO must contribute to the achievement of at least one (1) of the following objectives:

  • To support the development of science and technology relevant to the priorities of the CSA.
  • To foster the continuing development of a critical mass of researchers and HQPs in Canada in areas relevant to the priorities of the CSA.
  • To support information gathering, studies and research related to space.

4 APPLICATIONS

In this section

4.1 Required Documentation

A structure for the detailed project description is included in Appendix 2. Applicants are strongly encouraged to follow this structure.

Applicants are required to submit a full proposal prepared in English or in French, which shall include:

  • A completed original application form (Word, 105 KB) signed by the duly authorized representative and the PI of the proposed project as stipulated in section 3.2;
  • A copy of the document(s) confirming the legal name of the applicant (must be confirmed by the organization's Office of Research);
  • Letters from other funding contributors confirming their contributions, if applicable;
  • Declaration on Confidentiality, Access to Information Act and Privacy Act form signed by the duly authorized representative (refer to the Applicant Declaration on Confidentiality, Access to Information Act and Privacy Act section included in the application form); and
  • For organizations in Quebec, M-30 Supporting Documentation form completed and signed by the duly authorized representative (refer to the M-30 form for organizations in Quebec included in the application form).
  • For not-for-profit organizations, an original or certified copy of their certificate of constitution, letters patent, or other constitutive documents. Non-original or uncertified copies are accepted for the purposes of the application, but the original documents will be required at the time of the signing of the agreement.
  • For Canadian Co-Is involved in an international study, a letter from the international PI is required, confirming that the proposed work by the Canadian Co-I will enhance the study;
  • Letter of support from Co-Is confirming their intent to participate to the study, including information on the potential source of funds, if applicable;
  • The applicant will ensure that ethical certification requirements are met throughout the study. A letter signed by the chairperson of the local Research Ethics Board (REB) regarding approval of the experimental protocol will be required to that effect or Animal Care Committee (when required). Ethics approval letters for any subsequent protocol amendments and renewal letters must also be forwarded to the CSA;
  • A Data Management Plan shall be provided with the proposal that addresses:
    • Type(s) of data products;
    • Short-term data preservation approach;
    • Long-term data preservation/archiving approach;
    • Format(s) for data and metadata;
    • Sharing and reuse of the data, when applicable;
    • Roles and responsibilities for data management within the team.

It is the applicant's responsibility to ensure that the application complies with all relevant Canadian legislation and bylaws (federal, provincial/territorial, and municipal).

The electronically uploaded application must be prepared as a single searchable PDF-formatted file (PDF/A-1a or PDF/A-2a formats preferred) containing all the above requested documents with all security features disabled. You are required to order the document with the application form and proposal first. If there are any accessibility issues with the submitted PDF file, all consequences will reside with the applicant.

The applicant must keep one hard copy of all the original documents above. The CSA may require applicants who successfully passed the evaluation stage described in Section 5 of the AO to send a hard copy of their complete application with the original documents.

Process for electronic submission:

  • The applicant must complete an account creation request at the Electronic Proposal Portal. Upon receipt, the CSA will send an email with instructions on how to connect to the CSA secure file system to allow you to upload documents securely. Note that Chrome is the browser of choice for submissions. Supported browsers are Google Chrome, Firefox, and Internet Explorer with some restrictions.
  • Allow up to 72 hours for the CSA to send an email confirming the account creation as well as instructions (user guide) on how to access the platform. It is strongly recommended that the account creation request be submitted no later than . If technical issues cannot be resolved, applicants must submit their application by mail. Applicants are strongly encouraged to upload their complete application well before the submission deadline.
  • Using the temporary password assigned by the CSA, login to the secured portal to upload protected documents;
  • Refer to the user guide for instructions on how to securely upload documents.
  • Applications must be submitted (successfully uploaded) by applicants no later than 2:00 PM (EDT), ;
  • Incomplete or late applications shall not be considered. A late application has an electronic timestamp on the CSA system after the deadline above.

Process for application sent by mail:

The applicant is encouraged to submit their application electronically following the instructions provided in Section 4.1 of the AO. However, if the applicant is unable to submit their application electronically, please communicate with santespatiale-spacehealth@asc-csa.gc.ca no later than 2:00 PM (EDT) to obtain instructions on how to submit a paper application by mail.

For application sent by mail, one (1) original paper copy of the full proposal, with a completed original application form (Word, 105 KB) signed by the duly authorized representative is required. In addition, one (1) copy of the application (identical to the signed paper copy) in a PDF file (on a USB flash drive) is required. If there is any discrepancy between the hard and the soft version, the hard copy takes precedence.

Applications by mail must be received at the CSA no later than at 2:00 PM (EDT). Applications sent by email will not be accepted. Incomplete applications may not be considered. The CSA is not responsible for any delays under any circumstances and will refuse applications that are received after the stipulated deadline.

Questions and answers related to this AO will be posted on the CSA website in the Frequently Asked Questions (Section 9).

Important information:

  • Proposals must be received at the CSA no later than at 2:00 PM (EDT).
  • Applications sent by email will not be accepted.
  • Incomplete applications may not be considered.

Questions and answers related to this AO will be posted on the CSA website in the Frequently Asked Questions (Section 9).

4.2 Service Standards – Complete Applications

Applicants will be notified in writing of decisions regarding their application. Selected applications will be announced on the CSA website. The CSA has set the following service standards for processing times, acknowledgement of receipt, funding decisions and payment procedures.

Acknowledgement: The CSA's goal is to acknowledge receipt of proposals within two (2) weeks of receiving the completed application package.

Decision: The CSA's goal is to respond to the proposal within 46 weeks of the AO's closing date and to send a contribution agreement for signature within 18 weeks after formal approval of the proposal.

Payment: The CSA's goal is to issue payment within six (6) weeks of the successful fulfillment of the requirements outlined in the contribution agreement.

Compliance with these service standards is a shared responsibility. Applicants must submit all required documentation in a timely fashion. Service standards may vary by Announcement of Opportunity.

5 EVALUATION

In this section

5.1 Evaluation Process

Applications will first be evaluated for eligibility. Only applications that have passed the eligibility assessment described in (Section 5.2) will be given further consideration.

Once the eligibility is confirmed, full proposals will then undergo a programmatic evaluation (Section 5.3) based on criteria such as benefits to Canada, project feasibility, resources, results and impacts as well as risk and risk mitigation measures. This step will be followed by a scientific merit review based on the peer-review criteria (Section 5.4). The scientific merit review will be conducted by a panel of scientific or technical experts. The number and diversity of experts required will be determined by the response to this research announcement and by the variety of disciplines represented in the proposals. The scientific merit review panel will assign a score from 0 to 100 or a designation of "not recommended for further consideration" based upon the intrinsic scientific merit of the proposal. Before a final decision is made, the CSA's Program Manager responsible for this AO may seek input and advice from other organizations, including (but not limited to) federal, provincial, territorial, and municipal government agencies and organizations. This score will reflect the consensus of the panel. Proposals that receive a score in the scientific merit review that is lower than 70/100 will not be further evaluated.

The final score for each proposal will be based on the score for program alignment (50%) and science merit (50%). Funding agreements will be offered to the applicants in the rank order based on the final score of the proposals while allowing considerations to maximize the use of available funding. The number of projects funded under this AO will depend on funding and resource availability.

5.2 Eligibility assessment

Eligibility of proposals will be based on these aspects:

  • Represents an eligible recipient as defined in Section 3.1;
  • Represents an eligible project as defined in Sections 3.23.3 and 3.4;
  • Meet program funding provisions in section 6 Funding.

An evaluation committee will screen applications according to the eligibility criteria described in Table 4 in Appendix 3.

5.3 Programmatic evaluation

Submissions will be evaluated using the graded criteria listed in Table 2. A detailed description of these criteria can be found in Appendix 4.

Table 2. Summary Table of Programmatic Criteria
Criteria Max score Min score Poor Average Good Excellent
1.Benefits to Canada 55 27
1.1 Links with the priorities of the CSA and its HLS Program 25 15 0 15 20 25
1.2 Benefits on Earth 20 10 0 10 15 20
1.3 HQP development 5 1 0 1 3 5
1.4 Equity, diversity, and inclusion (EDI) 5 1 0 1 3 5
2. Project FeasibilityFootnote 1, Resources, and Risk Assessment 40 20
2.1 Budget, Resources Allocation, and schedule 20 10 0 10 15 20
2.2 Risk Management 20 10 0 10 15 20
3. Science dissemination plan 5 1 0 1 3 5
Total 100 60Footnote 2

5.4 Scientific Merit evaluation

The eligible projects will then undergo a scientific merit peer-review that will be conducted based on the criteria in Table 3. To be considered eligible for funding, the total score obtained for these graded criteria must be at least 70/100.

The scientific merit review will be conducted by a panel of scientific experts according to the language ladder listed in Table 3; a detailed description of each criterion can be found in Appendix 5. For any given criterion, a score within the associated range will be assigned by each reviewer. The scientific merit review panel will assign a score from 0 to 100 or a designation "not recommended for further consideration" based on the intrinsic scientific merit of the proposal. Passing proposals must receive at least a minimal score for each criterion and obtain a total score of at least 70, which is higher than the sum of all the minimal scores. The peer-review panel will also provide comments to the CSA on the proposed budget.

Table 3 - Science Merit Scores
Criteria Maximum points for evaluation Minimum to pass Poor Average Good Excellent
Science quality 40 20
Originality 20 10 0-4 5-9 10-15 16-20
Impact 20 10 0-4 5-9 10-15 16-20
Research approach 30 18
Validity 10 6 0-2 3-4 5-6 7-10
Methodology 10 6 0-2 3-4 5-6 7-10
Potential pitfalls 10 6 0-2 3-4 5-6 7-10
Research team 30 10
Expertise and complementarity 15 5 0-4 5-8 9-12 13-15
Experience and productivity 15 5 0-4 5-8 9-12 13-15
Total 100 70Footnote 3

6 FUNDING

In this section

6.1 Available Funding and Duration

The maximum funding amount given in contribution for each project will be $900,000 for new Canadian projects over a maximum period of three (3) fiscal years.

The number of projects funded under this AO will depend on funding availability.

To determine the amount of funding to be allocated, consideration will be given to the availability of CSA funds, the total cost of the project, and the other confirmed sources of funds provided by other stakeholders and the applicant. The CSA reserves the right to reject any proposals or reduce the amount of the contributions at its entire discretion.

6.2 Eligible Costs

Eligible costs are costs that are essential to carry out the Project, reasonable and directly related to the Project to achieve the expected results of the Project. The costs are to be incurred directly by the applicant. Incurred Costs means any expense made to carry out the Project related to an Eligible Cost which is due and payable. CSA will not contribute to costs Incurred prior to the coming into force of a Funding Agreement and after the Project Completion Date.

Note that for this AO, the proposal cannot include as eligible any costs related to non-Canadian-based Co-Is or non-Canadian-based PIs or their work within the proposal. These costs should be submitted to the appropriate national agency for funding.

The eligible costs for contributions under this AO are the following:

  • Access fees;
  • Accommodation and meals allowances;
  • Bursaries fees;
  • Consultant services fees;
  • Cost of laboratory analyses services;
  • Costs related to acquisition, development and printing of materials;
  • Costs related to acquisition or rental of equipment;
  • Costs related to obtaining security clearance;
  • Costs related to publishing and communication services;
  • Costs related to training;
  • Data acquisition fees;
  • Data management fees;
  • Launcher services fees;
  • Licenses and permits fees;
  • Material and supplies fees;
  • Overhead (administrative) costs (not to exceed 20% of eligible costs for Canadian universities and 15% for other eligible recipients);
  • Participation fees at conferences, committees and events;
  • PST, HST and GST net of any rebate to which the recipient is entitled to and the reimbursement of any taxes for goods and services acquired in a foreign country net of any rebate or reimbursement received in the foreign country;
  • Registration Fees;
  • Salaries and benefits;
  • Translation services; and
  • Travel.

Under no circumstances can the total amount of assistance from governmental sources (federal, provincial, territorial and municipal) to the recipient exceed 100% of the total project cost.

Applicants must identify all sources of funding in their applications and confirm this information in a funding agreement if the project is selected for funding. Upon completion of a project, the recipient must also disclose all sources of funding.

7 FUNDING AGREEMENTS

In this section

7.1 Agreement

Upon favourable review of the applications, CSA will send a Contribution agreement to the successful applicant. The Contribution agreement will outline the rights, roles, and obligations of each respective party. In the event of any discrepancies between this AO and a Contribution agreement between CSA and the recipient, the latter document will take precedence.

For greater clarity, no liability and no commitment or obligation exist on the part of the CSA to issue a Contribution payment to the applicant until a Contribution agreement is signed by both parties. Furthermore, any costs or expenses incurred or paid by the recipient prior to the execution of a written Contribution agreement by both parties are the sole responsibility of the applicant, and no liability exists on the part of the CSA.

7.2 Payments

The CSA and each of the successful applicants (the recipients) will sign a funding agreement which is a condition for any payment made by the CSA with respect to the approved project.

Payments for contribution agreements will be made in accordance with the process and the reporting requirements described in the signed funding agreement. Upon notice of a successful application, the CSA will have no liability until a funding agreement is signed by both parties. Only eligible costs incurred after the funding agreement is signed and indicated in the agreement will be reimbursed.

7.3 Audit

The recipient of a funding agreement shall keep proper records of all documentation related to the funded project, for the duration of the project and for six (6) years after the completion date of the project, in the event of an audit. This documentation shall be available upon request.

7.4 Intellectual Property

All intellectual property developed by the recipient in the course of the project shall vest in the recipient. The recipient will undertake to protect all intellectual property he will possess, acquire or develop during the project.

7.5 Organizations in Quebec

7.5.1 Act Respecting the Ministère du Conseil exécutif, CQLR c M-30

An organization in Quebec whose operations are partially or fully funded by the province of Quebec may be subject to the Act Respecting the Ministère du Conseil exécutif, CQLR Chapter M 30.

Under Sections 3.11 and 3.12 of this Act, certain entities/organizations, as defined in this Act, such as municipal bodies, school bodies, or public agencies, must obtain an authorization by the Secrétariat du Québec aux affaires canadiennes (SQRC), as indicated by the Act, before signing any funding agreement with the Government of Canada, its departments or agencies, or a federal public agency.

Consequently, any entity that is subject to this Act is responsible for obtaining such authorization before signing any funding agreement with the Government of Canada.

Quebec applicants must complete, Section 8A of the application form

7.5.2 Loi sur la langue officielle et commune du Québec

La Loi sur la langue officielle et commune du Québec, le français (LLOQ) changes section 55 of the Charter of the French Language and came into force on June 1st 2023. Since that date, the conclusion of a G&C Agreement in English in Quebec is subject to the following conditions for the recipient to be bound by the Agreement:

  • A French version of the Agreement must be produced including the Schedules and must be given to the recipient before the signing of the English version.
  • The recipient must consent to signs the Agreement in English and continue communications in English thereafter.
  • Only one Agreement must be signed, either the French or English version.

7.6 Organizations in Alberta

An organization located in Alberta may be subject to the Provincial Priorities Act (Chapter P-35.5) (the Act) and its Provincial Priorities Regulation (Alberta Regulation 21/2025) (the Regulation).

As per section 2 of the Act, provincial entities listed in the Act and Regulations must obtain prior approval from the Government of Alberta in accordance with the process set out in the Act and in the Regulation before entering into an agreement with the Government of Canada.

Therefore, any entity that falls under the application of the Act or the Regulation must obtain such authorization prior to entering into an agreement with the Canadian Space Agency.

Applicants having activities in Alberta must complete Section 8C of the application form.

7.7 Performance Measurement

The CSA will ask the recipients to report on various performance measurement indicators throughout the execution of the project.

Examples include but are not limited to:

  • Space research and development advances sciences, technologies, applications and expertise- Number of highly qualified personnel involved in projects funded by CSA.
  • Science excellence - Number of scientific peer-reviewed publications acknowledging CSA funding.
  • Knowledge Creation
    • Knowledge production (including publications)
    • Presentations
    • Intellectual property (including patents)
  • Capacity Building
    • Project's research team (including HQPs supported)
  • Collaboration
    • Partners' contributions
    • Partnerships
    • Multidisciplinarity

As a courtesy, the CSA would like to receive a copy of publications arising from the work, and to be informed in advance of significant press releases or media interest resulting from the work.

7.8 Open Access Publications

If publications result from the project, the CSA wishes to promote the dissemination of findings that results from the projects it funds as quickly and to the greatest number of people as possible. Improved access to scientific results not only allows scientists to use a broader range of resources and knowledge, but also improves research collaboration and coordination, strengthens citizen engagement and supports the economy.

Thus, the CSA promotes the use of open access publication and archiving by recipients in order to facilitate the widest dissemination of findings that results from its funded projects. Thus, recipients are invited to publish, in a timely matter, their articles by using one of the following methods:

  1. Accessible online repository (institutional or disciplinary) so that the publication is freely accessible.
  2. Journal offering open access to articles.

It should be noted that these two methods are not mutually exclusive and that recipients are encouraged to use both.

Finally, the CSA wishes to receive, as a courtesy, a copy of the publications (if not freely accessible) or the hyperlink (if freely accessible) and its digital object identifier (DOI). These will be used to improve accessibility by including them in the CSA publications directory.

8 FREQUENTLY ASKED QUESTIONS (FAQ)

It is the responsibility of the applicants to obtain clarification of the requirements contained herein, if necessary, before submitting an application.

For any questions related to the AO, applicants shall use the following generic email address (santespatiale-spacehealth@asc-csa.gc.ca). Questions and answers related to this AO will be posted on the CSA website in the FAQ section of this AO. The CSA will respond to questions received before at 4 PM (EST).

In , the CSA will hold a bilingual webinar to inform the Life Science community about this opportunity and answer questions related to the announcement. Registration to this webinar held through MS Teams is free and mandatory. If you are interested in attending this online event, please send an email before with your name, email address, institution, position and area of research, to the following address: Santé Spatiale-Space Health (ASC/CSA) (santespatiale-spacehealth@asc-csa.gc.ca). Connection information (internet and telephone) will be provided to you by email.

Please note that email communication does not meet government data protection requirements.

  • Question 1: Is the budgeted $900 000 distributed across three years or is it per year?

    Answer 1: The $900 000 is distributed across the three years.

  • Question 2: With a third-party agreement, the costs for renting the equipment, testing and preparing the hardware would seem much higher than the budget available in this announcement. What is the recommendation for that?

    Answer 2: The potential third-party companies listed in Appendix 1 of the AO have mentioned several milestones where payment would be required. Payment would not be required as a whole at the beginning of the project. With the payment schedule, this budget should be sufficient to cover the cost of the contract, as well as other expenses for the science team.

  • Question 3: Will the sum of funding be enough money or will each team need to leverage in other projects to contribute to this project?

    Answer 3: The contribution should be sufficient to cover the contract itself as well as the cost for the science team. It is a significant budget for one or maybe two flights, depending on the cost estimate from the company.

  • Question 4: Is it possible to get samples from the people that will be on board the ISS, such as saliva?

    Answer 4: In the context of this AO, the astronauts onboard the ISS cannot be human subjects. There could be astronauts taking care of the experiment, installing it on the station, or recovering the hardware.

  • Question 5: Will there be payload space available to Canadian scientists on board the ISS?

    Answer 5: Canada has an allocation on the ISS, which will cover transportation as well as lab space on the ISS. This is not included in the contract or the contribution funds. The companies will provide payload space for the investigation.

  • Question 6: Does $900,000 budget need to cover the actual space flight? Does the budget cover something we're designing to go to the ISS? Is the funding meant to cover the launch as well as the time on the ISS?

    Answer 6: The launch services providers will establish a contract with the science team to cover the launch cost that would include launch preparation, safety reviews and landing the hardware.

    The cost of ISS resources such as crew time and transportation will be assumed by the CSA, except if provided by the company.

    Expenses from the science team, to support students, hardware, equipment, lab costs, etc., must be included in the proposal budget and will be covered by the funding agreement.

  • Question 7: Would ground analog experiments to compare with samples from the ISS be within the scope of what this AO is imagining?

    Answer 7: It is entirely possible to do some ground controls or a similar experiment on the ground to compare with the results of the flight experiment. The cost for these activities must be included in the budget.

  • Question 8: How long do you think these experiments run? In other words, how often are things going up and down?

    Answer 8: The companies mentioned that 12 to 18 months are required from the start of the contract, before the experiment is ready to launch. The timing will depend on the company, and on the complexity of the experimental setup.

    It is expected that most of the in-flight operation will happen in the following two years.

    Depending on the flight opportunities and on the experiment, launch and recovery of the sample will take maybe one to two weeks.

    The hardware as well as the experiment will be brought back to the science teams to continue the investigation.

  • Question 9: Can the service providers be from outside of Canada? Do we have to choose only from the list you have given?

    Answer 9: The service provide can be Canadian or international. The list in Appendix 1 is not exhaustive.

  • Question 10: I am studying cognitive interaction, stress management and team dynamics. Is this an eligible research topic under this solicitation?

    Answer 10: The project cannot involve any astronaut except for transportation and installation of the hardware that includes the experimental set up. If an animal or a cellular model can provide some information on the question, the project is eligible.

  • Question 11: Could we test the system with human participants outside in analogs, for example? Are we allowed to do so?

    Answer 11: Not in the context of this AO.

  • Question 12: With the plan to fund an estimated four projects, will all four have flight opportunities?

    Answer 12: Yes, all four will have flight opportunities.

  • Question 13: We also can get some astronaut time during flight for changing media and such and that would be through the CSA. We arrange that, is that correct?

    Answer 13:Service providers have some hardware that can perform limited cell culture operations, and astronauts will not be expected to be involved in the manipulation of the biological samples.

  • Question 14: With some of the third-party providers, they listed or showed pictures of astronauts putting in the fixative, but presumably they've automated it since or some of them have the automated capabilities. Should this be a question for them so that there be limited astronaut time, is that correct?

    Answer 14: That is correct. Some of the companies have automated capabilities. They can move some reagents, even take samples or refrigerate the biology. This must be confirmed with each company.

  • Question 15: You mentioned virulent microorganisms, does that include level 2 microorganisms such as Salmonella, Legionella, Steria, Chlamydia?

    Answer 15: If some service providers can provide facilities with the appropriate level of containment and if they can support this kind of microorganisms then they will be eligible.

    The CSA can investigate which organisms are acceptable for the ISS if a new question is submitted.

  • Question 16: Do the projects need to be self-contained, so that there will be minimal manipulation in space? How long is a flight into space? What amount of time should we be planning for?

    Answer 16: It will depend on the biology, on the equipment that is provided and the capability of the service provider. Overall, it is expected that such an experiment could last about one to three weeks. Some of the equipment can preserve the samples in cold storage so that the samples can wait for the next returning opportunity.

  • Question 17: The period for sending questions related to this AO ends two weeks before the due date. Can it be extended?

    Answer 17: To clarify, the questions can be submitted from the release of the announcement to 10, 2026, due to the time required to answer, translate and publish the questions for the whole community.

  • Question 18: Can we propose a research model that uses human cells derived in a 2-dimensional or 3-dimensional in vitro system?

    Answer 18: Yes, we welcome any models based on human cells, but not whole humans.

  • Question 19: Section 1B of the application form is about the organization, history and scope. What information is required?

    Answer 19: The list of information required is in the application form.

  • Question 20: Can researchers seek out Canadian for-profit contractors to support the development of the payload? Is there a maximum percentage of the contribution that can be allocated to these contracting services?

    Answer 20: The investigators can seek out for-profit contractors to support development of the payload, and the contract would be between the eligible recipient (institution) and the for-profit contractor. There is no maximum percentage of the contribution that can be allocated to the contract.

  • Question 21: Can ISS crew time be expected / planned for, and if this is possible – will this be arranged through the CSA?

    Answer 21: ISS crew time will be dedicated by the CSA to selected projects, if not provided by the company. However, the total crew time estimated in the proposal will influence the feasibility of the project and the funding decision, considering that crew time is a limited resource.

APPENDIX 1: Examples of Companies Enabling Life Science Research in Microgravity Environments

In recent years, a growing number of commercial companies have developed platforms that enable scientific research aboard the ISS and potentially other orbital platforms. Each company offers distinct capabilities, equipment, and support specific research models, allowing researchers to select the most suitable partner based on their experimental needs.

Below is a concise overview of some of the commercial providers, their services, and their website where those interested can further engage with them. Please note that, while not exhaustive, this list is intended to illustrate the range of potential opportunities and assist researchers in identifying relevant partners for their scientific and technological projects. For example:

BioServe Space Technologies

BioServe is a full-service organization that can guide the novice or experienced researcher, organization or company through the process of conducting fundamental or applied research, in space manufacturing or technology development on board the International Space Station (ISS) or other space flight vehicles and platforms.

Select ISS-Certified Hardware include:

Services include:

ICE Cubes Service

ScienceCube, is a compact, flight-proven minilab available in two configurations: Mk1 supports up to six samples with passive exposure at ambient temperature and remote camera monitoring, while Mk2 doubles the capacity to twelve samples and includes active thermal control for temperature-sensitive biological studies. Both versions support a wide range of research models including fungi, bacteria, seeds, fluids, cell cultures, biomaterials, and small organoids. ICE Cubes also offers specialized platforms like Kirara for protein crystallization and Media Set for audiovisual communication, edge computing, healthcare applications, and human research experiment support. Researchers benefit from 24/7 remote access to their experiments via a secure internet portal, with payloads supported by customizable hardware, rapid deployment timelines, and full operational assistance from concept to return.

Voyager Technologies (Voyager | Defense & Space Technology)

A laboratory that enables and supports both in vitro models (cell cultures, organoids, tissue chips) and in vivo models (C. elegans, fruit flies, and potentially other species), enabling systemic biological studies in microgravity. Voyager has worked in over 1400 completed space missions with projects using: automated bioreactors, lab-on-a-chip systems, fluorescence and confocal microscopes, cryogenic freezers and incubators, microgravity-adapted centrifuges, spectrophotometers, and protein crystallization chambers. Additional tools may include tissue engineering scaffolds for regenerative medicine, microfluidic devices for precise fluid control, and wearable biosensor interfaces for real-time biological monitoring.

Redwire Space

Redwire research models span cellular biology, cancer organoids, 3D and neural tissue engineering, plant genetics, and microbiology. Among their facilities is the BioFabrication Facility (BFF), a bioprinter with a temperature-controlled chamber that has successfully printed live human heart tissue and meniscus cartilage in orbit. The Pharmaceutical In-Space Laboratory (PIL-BOX), which enables the growth of crystals under microgravity conditions, features gradient temperature control, automated fluid handling, imaging systems, and rapid sample return containers, and has been used in collaborations with Eli Lilly and Butler University to develop antiviral and antiseizure compounds. Redwire also operates the Advanced Space Experiment Processor (ADSEP), an automated middeck locker system with three independent thermal zones and onboard computing for parallel experiments and real-time data logging. These platforms are designed to support both exploratory science and scalable biomanufacturing, with applications in tissue engineering, drug formulation, and crop improvement. Redwire currently manages over ten active facilities on the ISS and is expanding its capabilities through partnerships with Sierra Space and other commercial station developers.

Space Tango

Space Tango equipment supports research on organoids, stem cells, and cellular systems, with applications in regenerative medicine, oncology, and personalized drug discovery. The CubeLabs—miniaturized, self-contained labs ranging from 1U to 9U in size—that run autonomously once installed on the ISS. These units feature thermal control, fluidics for reagent delivery, small incubators, imaging systems (including cameras and microscopes), environmental sensors (humidity, CO₂), and automated data logging. The Mambo (Microgravity-based Automated Manufacturing and Bioprocessing Outpost) operates solely on the ISS and provides power and data to the CubeLabs only during on orbit experimentation. The Mambo also enables flexible, scalable automated solutions for research and manufacturing in microgravity environments. This facility is designed to support biomanufacturing and manufacturing production scale while providing real-time data streaming, power, and containment. Additionally, the PAUL (Powered Ascent Utility Locker) system provides power and data throughout all phases of flight, enabling live cell cultures to remain viable during launch and to initiate experiments immediately upon arrival in orbit. The PAUL can also support the return of live cell cultures from ISS to Earth.

Yuri

Yuri provides a variety of flight-proven experiment hardware for stem cells, organoids, microbes, crystals and plants. Extensive training on the hardware and enough dry runs in the lab will occur before the experiment goes into space. Yuri organizes an all-inclusive service (end-to-end), all hardware and tests, launch logistics, such as export control, safety, and launch bookings and labs at launch site. Upon return from space, the experiment is shipped back for analysis. Certain live data can be received while in space.

Their ISS hardware includes:

Services include:

Kayser Space

Kayser Space is part of Bioreactor Express, a consortium delivering an express way to do scientific and technological research in microgravity. This service can install experimental hardware inside the International Space Station on a commercial basis.

ISS Hardware available to support biology and biotechnology investigations includes:

Kayser Space can also offer services for the implementation of different life science investigations and support the development and certification of bespoke payloads suitable for manned spaceflight missions.

APPENDIX 2: Structure for the detailed project description

This document should contain sufficient detail to enable a reviewer to make informed judgments about the overall merit of the proposed research and the probability that the investigators will be able to accomplish their stated objectives. It should clearly indicate the relationship between the proposed work and the research emphases defined in the announcement. The development of a clear hypothesis, along with the available data evidence, should be emphasized. In addition, the proposal should provide evidence of completed or planned ground research to justify the flight experiment.

The cover page of the description must contain the title of the proposal, the name of the principal investigator and the legal name of the organization requesting the Contribution. The detailed description (maximum of 20 pages, excluding references) must include the following material in the proposed order:

  1. Summary
  2. Background
  3. Relevance to the announcement priorities
  4. Research hypotheses
  5. Methodology
  6. Research team's experience, roles, and responsibilities
  7. Requirement for in situ analysis
  8. Training plan
  9. Data management plan
  10. References

The document must be provided in a commonly used format (.DOC, .DOCX, .PDF, .RTF, .TXT), 12 pt type face, letter sized paper (8.5”x11”) and 2.54 cm (1") margins.

APPENDIX 3: Description of Eligibility Assessment Criteria

Table 4 - Summary of eligibility criteria
Criteria Description Scoring
Eligibility of the applicant This criterion evaluates whether the application has been submitted from an eligible recipient as defined in Section 3.1.

Pass
Definition: The organization is an eligible recipient for a contribution as described in Section 3.1 of this AO.
Fail
Definition: The organization is not an eligible recipient for a contribution as described in Section 3.1 of this AO.

Eligibility of the project This criterion evaluates whether the application is an eligible project for this AO as defined in Section 3.2.

Pass
Definition: The project is eligible for a contribution as described in Section 3.2 of this AO.
Fail
Definition: The project is not eligible for a contribution as described in Section 3.2 of this AO.

Links with CSA priorities This criterion evaluates how the project will contribute to the CSA priorities as defined in Section 3.3.

Pass
Definition: The proposal clearly demonstrates that the research objectives directly address one (1) or more health risks or needs for medical support of human space flight as described in Section 3.3.
Fail
Definition: The research does not address a risk or needs for medical support of human space flight as described in Section 3.3 or only indirectly addresses them.

Links with G&C Program priorities This criterion evaluates how the project will contribute to the G&C Program objectives, as defined in Section 3.4.

Pass
Definition: The proposal clearly demonstrates how the project will contribute to support the development of science and technology relevant to the priorities of the CSA, and that it will foster the continuing development of a critical mass of researchers and HQPs in Canada in areas relevant to the priorities of the CSA.
Fail
Definition: The proposal does not demonstrate how the project will contribute to support the development of science and technology relevant to the priorities of the CSA or that it will foster the continuing development of a critical mass of researchers and HQPs in Canada in areas relevant to the priorities of the CSA.

APPENDIX 4

In this section

1. Benefits to Canada

1.1 Links with the priorities of the CSA and its Space Health & Life Sciences Program

Description: This criterion evaluates whether the proposed research objectives are aligned with the priorities of the CSA and its HLS program. Do the research objectives directly address health risks associated with human space flights or needs for health and medical support (CSA priorities in section 3.3)?

Minimum score required = 15

Poor:

The research objectives in the proposal do not address a risk or medical needs of human space flight as listed in section 3.3. (Score: 0)

Average:

One (1) research objective in the proposal addresses one (1) direct risk or medical needs of human space flight as described in in section 3.3 and describes how the risk is addressed, but the description is superficial or incomplete. (Score 15)

Good:

At least one (1) of the research objectives in the proposal directly address one (1) or more risks or medical needs of human space flight as described in section 3.3 and the proposal clearly describes how the risk is addressed. (Score: 20)

Excellent:

All research objectives in the proposal directly and clearly address one (1) or more risks or medical needs of human space flight as described in section 3.3. The proposal includes a well-considered projection about the potential pathway between the proposed research and an operational countermeasure (i.e., a measure that is implemented on a future space flight). (Score: 25)

1.2 Benefits on Earth

Description: This criterion evaluates whether the proposal demonstrates that the proposed research may contribute to the advancement of understanding of similar health issues or applications on Earth, or that could contribute to improving health care for Canadians. Provide a clear explanation of how specifically this research can bring benefits on Earth (i.e., which specific population, how it will benefit that population, etc.).

Minimum score required = 10

Poor:

The proposal does not address benefits on Earth, or the case for benefits is not clear or logical. (Score: 0)

Average:

The proposal indicates benefits on Earth, and the justification is included but it is general, or lacks precision. (Score: 10)

Good:

One (1) or more of the research objectives has direct Earth benefits. A specific justification is provided and adequate. (Score: 15)

Excellent:

Justification on how the proposed research will directly contribute to the advancement of understanding of similar health issues or to improve health care for Canadians is clear, thorough and persuasive. (Score: 20)

1.3 HQP development

Description: This criterion evaluates how the project will foster the development of HQPs, through recruitment of qualified students/postdoctoral fellows/trainees and provide them with an integrated and meaningful role in the project research team. The proposal must include a clear description of both the role and responsibilities of students/HQPs, and a plan for their development.

Minimum score required = 1

Poor:

The proposal does not include a plan to foster the development of students/postdoctoral fellows/trainees. (Score: 0)

Average:

The proposal contains a development plan. Role of students/postdoctoral fellows/trainee candidates is stated but lacks details. (Score: 1)

Good:

The proposal contains a detailed plan to develop students/postdoctoral fellows/trainees and provides realistic assurance on its feasibility. Their role in the team is well defined. (Score: 3)

Excellent:

The proposal contains a well-thought-out plan to develop students/postdoctoral fellows/trainees. Description on how this plan will be achieved is complete. The proposal demonstrates that HQPs will be assigned leadership roles appropriate for their educational status. (Score: 5)

1.4 Equity, diversity, and inclusion (EDI)

Description: The research project must meaningfully engage members of underrepresented groups within the research team as students, postdoctoral fellows, faculty, and partners. Underrepresented groups include, but are not limited to, the four (4) designated groups (women, Indigenous peoples, members of visible minorities, and persons with disabilities). Applicants can consult the Employment equity website for definitions of each group.

This criterion evaluates whether the proposal describes the specific means that will be taken to foster recruitment and engagement of members from these underrepresented groups within the research team.

It also evaluates the different outreach activities proposed by investigators or the research team aiming the engagement and inclusion of underrepresented groups, inside or outside of the research laboratories or universities/institutions (e.g.: participation to committees and boards, conferences/colloquiums, workshops, and public dialogues).

  • Note that journal club or lab meetings are not considered outreach activities with members of the underrepresented groups.
  • Referencing the university policy is not considered a sufficient demonstration.

Minimum score required = 1

Poor:

The proposal does not describe any measure to facilitate the diversity of the team and does not mention any outreach activities. (Score: 0)

Average:

The proposal contains a diversity inclusion plan or mentions only one (1) outreach activity. The explanation of how this plan or this activity will be achieved lacks details. (Score: 1)

Good:

The proposal contains a diversity inclusion plan that describes specific means to foster recruitment and engagement of members from underrepresented groups or mention at least two (2) outreach activities. The explanation of how this plan or these activities will be achieved is mainly complete and the approach appears feasible. (Score: 3)

Excellent:

The proposal contains a diversity inclusion plan that is fully described, with detailed information on the specific means that will be used to implement the plan (i.e., underrepresented groups that are not included currently in the team and that are targeted) or contains at least three (3) outreach activities that are well detailed and described. (Score: 5)

2. Project Feasibility, Resources, and Risk Assessment

2.1 Budget, Resources Allocation and Schedule

Description: This criterion evaluates the adequacy of the budget, resource allocation to tasks, level of effort, and material resources as well as project schedule. Applicants must present in their application an itemized budget that clearly describes project expenditures and sources of funding. Justification for the requested funds needs to be complete and detailed. The application must also show resource (human and funds) allocation to tasks, and level of effort for everyone involved in the project (description and/or percentage), as well as project schedule. Applicants are encouraged to seek co-funding and should clearly indicate co-funding in their budget.

Minimum score required = 10

Poor:

The proposal presents an incomplete or inadequate description of budget, resource allocation, and schedule, and/or inadequate justification of project expenditures. (Score: 0)

Average:

The budget, resource allocation and schedule are presented, however, some information may be missing, or the justification of expenditure may sometimes be incomplete, or some expenditures are not defined well enough. (Score: 10)

Good:

Appropriate budget and allocation of resources are presented. Level of effort is included and appears adequate. Schedule planning is feasible and realistic. Justification of project expenditures is appropriate with no major omissions. (Score: 15)

Excellent:

The budget, resource allocation, and schedule are presented in a detailed and clear manner. Justification of resources is clear and comprehensive. The allocation of resources and level of effort, with clear and comprehensive justification are provided. (Score: 20)

2.2 Risk Management

Description: This criterion evaluates the knowledge of potential pitfalls and obstacles that may occur during the project, as well as the adequacy of proposed preventive/remedial measures. The proposal shall address key risks associated with the project and the mitigation strategies for each. Information should be provided on resource availability, risks associated with their non-availability, and the risk and mitigation strategies associated with those risks. The following points are particularly important:

  • Has the applicant identified and described in detail the key risks associated with the project, including, but not limited to financial, technical (i.e., execution of research protocols, REBs approval), and managerial risks (i.e., human resource back-up plans in case of unavailability of a team member)?
  • Are the probability of occurrence and the impact realistic?
  • Are the resources available to the research team, or was an agreement made to ensure implementation of the project?
  • Are the mitigation strategies for each risk correctly addressed and realistic?

Minimum score required = 10

Poor:

The proposal does not identify any key risks or mitigation strategies, or some risks may be identified but related mitigation strategies are missing. (Score: 0)

Average:

The proposal identifies some, but not all key risks; mitigation strategies are defined. However, the information provided is not sufficient and some details are missing. (Score: 10)

Good:

The proposal demonstrates general understanding of key risks and potential pitfalls for this type of project and proposes elements of preventive/remedial measures to ensure feasibility of the study and their justification is well developed. (Score: 15)

Excellent:

The proposal demonstrates clear understanding of key risks and obstacles/pitfalls accompanied by a thorough and adequate discussion of preventive/remedial measures to ascertain completing the study and achieving quality results. Key risks and their mitigation strategies are well described, and the risk assessment is realistic. (Score: 20)

3. Science dissemination plan

Description: This criterion evaluates the science dissemination plan describing how results from the investigations will be disseminated (i.e., conferences, publications, etc.). Per Section 7.7, applicants are encouraged to use open access publications and archiving to facilitate dissemination of results from the investigation.

Minimum score required = 1

Poor:

The proposal does not include a science dissemination plan. (Score: 0)

Average:

The proposal indicates some provisions for science dissemination, but few details are provided about this plan and the proposal does not clearly establish if open access publications will be used, and whether there will be presentation at conferences. (Score: 1)

Good:

The proposal includes a realistic plan to disseminate scientific results to the scientific community, the use of open access publications and participation to conferences are also indicated. (Score: 3)

Excellent:

The proposal includes an explicit, well thought-out, and structured scientific publication plan to disseminate scientific results using open access publications and presentation at conferences, and the plan is likely to raise Canada's profile in space life science considerably. (Score: 5)

APPENDIX 5: Description of Evaluation Criteria for Scientific Merit

In this section

Science quality

Originality

Description: This criterion evaluates whether the proposal addresses a significant gap in health research related to spaceflight.

Minimum score required = 10

Poor:

The hypotheses and research questions have been explored before. (Score: 0-4).

Average:

The hypothesis/research questions contain limited original elements and represent incremental research. (Score: 5-9).

Good:

The hypothesis/research questions are original and represent a new approach. The project is likely to result in significant scientific advances. (Score: 10-15).

Excellent:

The hypotheses/research questions are built on ground research but have not been investigated before in space. The project is likely to result in scientific breakthrough. (Score: 16-20)

Impact on health risk understanding and mitigation

Description: This criterion evaluates the potential of the proposal to decrease one (1) or more risks of human spaceflight if the objectives are met. Potential to increase our understanding of the risks associated with human spaceflights and to propose mitigation strategies will be evaluated. Potential to address specific needs for health and medical support of spaceflight crews. This criterion mainly addresses the expected outcome of the proposed research in the context of risk understanding and mitigation.

Minimum score required = 10

Poor:

The study is unlikely to increase our understanding of the risks of human spaceflight, provide any mitigation strategy, or address needs for medical support of crews. (Score: 0-4).

Average:

The study will only marginally increase our understanding of the risks of human spaceflight but does not provide insights into mitigation strategies or needs for medical support of crews. (Score: 5-9).

Good:

The study is likely to increase our understanding of the risks of human spaceflight and lead to substantial insights into a mitigation strategy but does not address needs for medical support of crews. (Score: 10-15).

Excellent:

The study is very likely to provide a critical increase of our understanding of the risks of human spaceflight and a credible, novel mitigation strategy for one (1) or more specific health risks of human spaceflight. The proposal describes how the research will lead to a countermeasure and address a need for medical support of crews. (Score: 16-20).

Research approach

Validity of the research approach

Description: This criterion evaluates how the research approach builds upon a successful foundation of ground or previous flight studies. It evaluates the completeness of the literature review and its relevance to the study design/research plan.

Minimum score required = 6

Poor:

The research approach is not based upon a successful foundation of ground or previous flight studies. The literature review is missing or inadequate/incomplete. (Score: 0-2).

Average:

The research approach is indirectly related to successful ground or previous flight studies. The literature review is missing or inadequate/incomplete. (Score: 3-4).

Good:

The research approach is based in part upon a successful foundation of ground or previous flight studies. The literature review contains some relevant references, but some important documents are missing. (Score: 5-6).

Excellent:

The research approach is largely based upon a successful foundation of ground or previous flight studies. The literature review is exhaustive and covers all aspects of the proposed study. (Score: 7-10).

Methodology

Description: This criterion evaluates the appropriateness of the proposed research design, research methods and feasibility of the research approach to achieve the objectives. Is the equipment by the third-party provider, appropriate for the proposed research model?

Minimum score required = 6

Poor:

The proposed methodology is unlikely to support the objectives of the study or is poorly described. The research design lacks important details, and the selected approach is not appropriate. (Score: 0-2).

Average:

The proposed methodology may support the study's objectives. However, there is a significant lack of details, or it is poorly described. There may be better approaches to achieve the objectives. (Score: 3-4).

Good:

The proposed methodology is likely to achieve the objectives and well described. However, some aspects of the methodology are not appropriate or well described. (Score: 5-6).

Excellent:

The proposed methodology is excellent and clearly described, giving a high level of confidence that the objectives will be achieved. (Score: 7-10).

Potential pitfalls

Description: This criterion evaluates how the proposal addresses project risks and whether it includes mitigation strategies.

Minimum score required = 6

Poor:

The proposal fails to identify and address potential pitfalls and does not include a risk mitigation strategy. (Score: 0-2).

Average:

The proposal identifies some of the potential pitfalls of the project but proposes inadequate mitigation strategies. (Score: 3-4).

Good:

The proposal identifies the major potential pitfalls and proposes an adequate mitigation strategy. (Score: 5-6).

Excellent:

The proposal clearly identifies all potential pitfalls and proposes an excellent mitigation strategy. (Score: 7-10).

Research team

Research team expertise and complementarity

Description: This criterion evaluates the availability of all the required expertise in the team to successfully accomplish the proposed work. Specific aspects of the evaluation include qualifications of the applicant(s) and appropriateness of the team to carry out the proposed research, in terms of complementarity of expertise.

Minimum score required = 5

Poor:

The proposed team does not have the required expertise, or the proposal does not address this criterion. (Score: 0-4).

Average:

The team has deficiencies in the completeness of the skills of its members, is lacking important expertise in field of research relevant to the study. The proposal suggests that the team may not be capable of achieving the objectives of the project. (Score: 5-8).

Good:

The proposal demonstrates that the team has most of the expertise required to achieve the objectives of the study, however some minor expertise may be lacking, or complementarity of the expertise is not optimal. (Score: 9-12).

Excellent:

The completeness of the team is very well demonstrated through the complementarities of skills of its members and by the roles/tasks that they are assigned during the study. The expertise of the proposed team demonstrates that it is highly capable of achieving the objectives. (Score: 13-15).

Research team experience and productivity

Description: This criterion evaluates the experience of the team in the proposed area of research as demonstrated by scientific productivity over the past five (5) years and past achievements in the proposed field of research and methodology. Addressing the productivity can be commensurate with the career stage of the team members, and consider extenuating factors (i.e. pregnancy, illness etc.).

Minimum score required = 5

Poor:

The team's scientific productivity in this field of research is poor and the experience in similar research studies is not sufficient. (Score: 0-4).

Average:

Although the team includes experts in the field of research, some members of the team have limited experience, or the overall productivity of the team is less than average. Experience of the team in the proposed area of research or with the proposed methodology is not clearly demonstrated. (Score: 5-8).

Good:

The team includes established members with good publication productivity in their field and some experience in similar studies. (Score: 9-12).

Excellent:

The team is composed of experts in the proposed field of research, with a high productivity in their field. The team has successfully conducted studies of similar scope. (Score: 13-15).

Date modified: